pe pagina
  • 129.00 lei

    This is a revision book to help pharmacist students prepare for the pre-registration exam of the Royal Pharmaceutical Society of Great Britain (RPSGB) and other similar exams. It consists of over 400 multiple choice questions (MCQs), with explanatory answ

  • 150.00 lei

    Oferta speciala! 185 lei 150 lei

    Lippincott's Illustrated Reviews: Pharmacology, Fifth Edition enables rapid review and assimilation of complex information and focuses on the essentials of medical pharmacology. Clear, sequential pictures present mechanisms of action and actually show, rather than tell, students how drugs work.

  • 160.00 lei

    Lippincott Illustrated Reviews: Pharmacology, Sixth Edition, is the updated, enhanced version of the student-favorite resource for essentials of medical pharmacology. The first-and-best resource, the Lippincott Illustrated Reviews series features clear, effective writing and hundreds of illustrations for ideal rapid review and the assimilation of complex information. Clear, sequential images present mechanisms of action and focus on showing rather than telling students how drugs work. New edition features:

    • All NEW chapters on Drugs of Abuse, Drugs for Obesity, Antihistamines, Drugs for Urologic Disorders, Drugs for Hematopoietic Disorders, Drugs for Dermatological Disorders, and Drugs for Bone Disorders
    • Over 380 study questions!
    • Nearly 600 annotated, full-color illustrations visually explain complex processes!
    • Outline format ideal for concise review and foundational learning

  • 175.00 lei

    Now fully updated for a second edition, the Oxford Handbook of Clinical Pharmacy remains the indispensible guide to clinical pharmacy, providing all the information needed for practising and student pharmacists. Presenting handy practical guidance in a quick-reference, bullet-point format, it will supply the knowledge and confidence you need to provide a clinical pharmacy service. The handbook includes information on controlled drugs, adverse drug reactions, interactions, communication skills, and confidentiality. It also features chapters on adherence, anaphylaxis, clinical trials, herbal medicines, patient management, pharmaceutical calculations, research, policy, and therapy related issues. Palliative care sections have been expanded to include symptom management and end-of-life pathways. Other new sections such as pharmacogenetics, thyroid disorders, and domiciliary oxygen therapy have been included. Complementing the current British National Formulary guidelines, the handbook gives prescribing points and linked concepts of relevance to clinical pharmacists. The content is evidence-based and contains a wealth of information from the authors' many years of clinical pharmacy experience.

  • 190.00 lei

    The most up-to-date, comprehensive, and authoritative pharmacology text in health medicine organized to reflect the syllabi in many pharmacology courses and in integrated curricula, Basic & Clinical Pharmacology, 13e covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors' many years experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. To be as clinically relevant as possible, the book includes sections that specifically address the clinical choice and use of drugs in patients and the monitoring of their effects, and case studies that introduce clinical problems in many chapters. Presented in full color and enhanced by more than three hundred illustrations, Basic & Clinical Pharmacology features numerous summary tables and diagrams that encapsulate important information. It explains everything students need to know about the science of pharmacology and its application to clinical practice. Includes 330 full-color illustrations, case studies, and chapter-ending summary tables. It is organized to reflect the syllabi of pharmacology courses Descriptions of important new drugs.

  • 190.00 lei

    A full-color manual derived from Goodman & Gilman's The Pharmacological Basis of Therapeutics. Goodman & Gilman's The Manual of Pharmacology and Therapeutics offers concise, authoritative coverage of class-specific and disease-specific drugs, organized primarily by organ/system. Derived from Goodman & Gilman's Pharmacological Basis of Therapeutics, Twelfth Edition and further updated, this streamlined text focuses on the principles of medical pharmacology and drug therapy and delivers coverage of all major drug classes. More than a pocket drug guide, this powerful resource covers: General Principles; Neuropharmacology; Modulation of Cardiovascular, Pulmonary, and Renal Function; Inflammation, Immunomodulation, and Hematopoiesis; Hormones and Hormone Antagonists; Drugs Affecting Gastrointestinal Function; Chemotherapy of Microbial Diseases; Chemotherapy of Neoplastic Diseases; and Special Systems Pharmacology, including Environmental Toxicology. The text explains the physiology and pathophysiology of major organ systems and pathogens with respect to pharmacotherapy and the mechanisms of drug action. With a new full color design and numerous tables, charts, and illustrations that highlight, explain, and summarize important information, Goodman & Gilman's Manual of Pharmacology and Therapeutics is essential wherever knowledge of drug actions and interactions is required

  • 220.00 lei

    The essential pharmacotherapy data you need for clinical practice and board preparation – in one carry-anywhere guide Pharmacotherapy Handbook provides the critical information you need to make drug therapy decisions for more than 140 diseases and disorders commonly encountered in a clinical setting. Featuring a convenient alphabetized presentation, this handy guide utilizes text, tables, figures, and treatment algorithms to make important drug data readily accessible and easily understood. Features: Consistent chapter organization includes: Disease state definition Concise review of relevant pathophysiology Clinical presentation Diagnosis Goals of treatment Treatment Monitoring Six appendices, including "Allergic and Pseudoallergic Drug Reactions" and "Geriatrics"

  • 224.00 lei

    What do we do if different studies appear to give different answers? When applying research to questions for individual patients or for health policy, one of the challenges is interpreting such apparently conflicting research. A systematic review is a method to systematically identify relevant research, appraise its quality, and synthesize the results. The last two decades have seen increasing interest and developments in methods for doing high quality systematic reviews. Part I of this book provides a clear introduction to the concepts of reviewing, and lucidly describes the difficulties and traps to avoid. A unique feature of the book is its description, in Part II, of the different methods needed for different types of health care questions: frequency of disease, prognosis, diagnosis, risk, and management. As well as illustrative examples, there are exercises for each of the sections. This is essential reading for those interested in synthesizing health care research.

  • 250.00 lei

    Catastrophes under anesthesia have focused attention on the interaction between drugs, including prescribed and non-prescribed medications, including interactions with vitamins, herbal preparations, traditional remedies, and food supplements. This book summarizes the adverse effects of a large range of drugs used in anesthesia.

  • 30000lei 260.00 lei

    Oferta speciala!!!  300 lei   260 lei

    For 25 years, Rang and Dale's Pharmacology has delivered the core basic and clinical science information required by students and healthcare practitioners worldwide. Authors H. P. Rang, J. M. Ritter, R. J. Flower, and G. Henderson have ensured that the 8th Edition of this easy-to-read, comprehensive text continues the tradition of excellence with new coverage of drugs affecting the skin and new components online at Student Consult. Get the essential pharmacology information you need from one authoritative source with an outstanding global reputation for excellence. Progress confidently through all relevant aspects of pharmacology, beginning with a molecular understanding of receptors and drug actions through clinical uses of key groups of drugs. Find important content quickly thanks to a color-coded layout that enables easy navigation and cross-referencing. Master difficult concepts with Key Points boxes, Clinical Uses boxes, and full-color illustrations throughout. Stay up to date with new information in the field, including an all-new chapter on drugs that affect the skin. Take advantage of new and unique features online, including 500+ chapter-specific multiple choice questions for immediate self-assessment. eBook version included!

     

  • 46200lei 430.00 lei

    With the range of psychotropic drugs expanding and the usages of existing medications diversifying, we are pleased to present this very latest edition of what has become the indispensable formulary in psychopharmacology. This new edition features seven new compounds as well as information about several new formulations of existing drugs. In addition, many important new indications are covered for existing drugs, as are updates to the profiles of the entire content and collection, including an expansion of the sections on long-acting injectable formulations of antipsychotics. With its easy-to-use, template-driven navigation system, The Prescriber's Guide combines evidence-based data with clinically informed advice to support everyone who is prescribing in the field of mental health.

    •  
    • Provides the most complete and up-to-date summary of the practical use of psychotropic drugs, including seven new drugs in this edition
    • Presented in a templated format, fully indexed and cross-referenced for ease of navigation
    • Written with the authority of evidence and the guidance of clinical wisdom

  • 46700lei 430.00 lei

    467 RON 430 RON

    Familiarly known as the "Orange Guide," this title is an essential reference work for all those involved in the manufacture or distribution of medicines in or for Europe. It is compiled by the UK drug regulatory body, the MHRA, and brings together the European and UK guidance documents and information on legislation relating to the manufacture and distribution of medicines for human use. It contains EU guidance on good manufacturing and good distribution practice along with relevant information on EU and UK legislation. This 2015 edition of Rules and Guidance for Pharmaceutical Manufacturers and Distributors (the Orange Guide) has been updated to incorporate changes made to Chapter 6 Quality Control of the detailed European Community guidelines on Good Manufacturing Practice (GMP) which came into operation on 1 October 2014 and the revised EU Guidelines on Good Distribution Practice.

  • 440.00 lei

    Responding to the increased scrutiny of drug safety in recent years, Quantitative Evaluation of Safety in Drug Development: Design, Analysis and Reporting explains design, monitoring, analysis, and reporting issues for both clinical trials and observational studies in biopharmaceutical product development. It presents the latest statistical methods for drug safety assessment. The book’s three sections focus on study design, safety monitoring, and data evaluation/analysis. The book addresses key challenges across regulatory agencies, industry, and academia. It discusses quantitative approaches to safety evaluation and risk management in drug development, covering Bayesian methods, effective safety graphics, and risk-benefit evaluation. Written by a team of experienced leaders, this book brings the most advanced knowledge and statistical methods of drug safety to the statistical, clinical, and safety community. It shares best practices and stimulates further research and methodology development in the drug safety area.

  • Drugs: From Discovery to Approval 3rd Edition
    by Rick Ng
    La comanda in aproximativ 4 saptamani
    467.00 lei

    The third edition of this best-selling book continues to offer a user-friendly, step-by-step introduction to all the key processes involved in bringing a drug to the market, including the performance of pre-clinical studies, the conduct of human clinical trials, regulatory controls, and even the manufacturing processes for pharmaceutical products. Concise and easy to read, Drugs: From Discovery to Approval, Third Edition quickly introduces basic concepts, then moves on to discuss target selection and the drug discovery process for both small and large molecular drugs. The third edition incorporates the latest developments and updates in the pharmaceutical community, provides more comprehensive coverage of topics, and includes more materials and case studies suited to college and university use. Biotechnology is a dynamic field with changes across R&D, clinical trials, manufacturing and regulatory processes, and the third edition of the text provides timely updates for those in this rapidly growing field.

  • 550.00 lei

    The landmark text on how to achieve optimal patient outcomes through evidence-based medication therapy Pharmacotherapy: A Pathophysiologic Approach is written to help readers advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. Readers will find everything they need to provide safe, effective drug therapy across the full range of therapeutic categories. This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest in evidence-based information and recommendations. Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students, patient-focused pharmacists, and other health care providers. Features: A section on personalized pharmacotherapy appears in most sections; All diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches are in full color to clearly distinguish treatment pathways; New drug monitoring tables have been added; Most of the disease-oriented chapters have incorporated evidence-based treatment guidelines that when available, include ratings of the level of evidence to support the key therapeutic approaches; Twenty-four online-only chapters are available at website.

  • 610.00 lei

    This volume will provide the reader with a good understanding of general pharmacological principles, together with knowledge of drugs likely to be encountered in both basic anaesthetic practice and current treatment of patients presenting for anaesthesia.

  • 613.00 lei

    Whilst following in the footsteps of previous volumes by presenting comprehensive reviews of drug substances and additional materials, this title also heralds a significant expansion of the scope of the series. Traditional contributions will now also be a

  • 670.00 lei

    THE LANDMARK TEXT ON HOW TO ACHIEVE OPTIMAL PATIENT OUTCOMES THROUGH EVIDENCE-BASED MEDICATION THERAPY Pharmacotherapy: A Pathophysiologic Approach is written to help you advance the quality of patient care through evidence-based medication therapy derived from sound pharmacotherapeutic principles. The scope of this trusted classic goes beyond drug indications and dosages to include the initial selection, proper administration, and monitoring of drugs. You will find everything you need to provide safe, effective drug therapy across the full range of therapeutic categories. This edition is enriched by more than 300 expert contributors, and every chapter has been revised and updated to reflect the latest evidence-based information and recommendations. Important features such as Key Concepts at the beginning of each chapter, Clinical Presentation tables that summarize disease signs and symptoms, and Clinical Controversies boxes that examine the complicated issues faced by students and clinicians in providing drug therapy make this text an essential learning tool for students, patient-focused pharmacists, and other health care providers. NEW TO THIS EDITION: A section on personalized pharmacotherapy appears in most sections All diagnostic flow diagrams, treatment algorithms, dosing guideline recommendations, and monitoring approaches have been updated in full color to clearly distinguish treatment pathways New drug monitoring tables have been added Most of the disease-oriented chapters have incorporated evidence-based treatment guidelines that often include ratings of the level of evidence to support the key therapeutic approaches Twenty-five online-only chapters are available at www.pharmacotherapyonline.com

  • 697.00 lei

    Description

    With a focus on functional relationships between drugs and their targets, this book covers basic and general pharmacology, from a cellular and molecular perspective, with particular attention to the mechanisms of drug action – the fundamental basis for proper clinical use- without neglecting clinical application, toxicology and pharmacokinetics.
    • Covers cell and molecular pharmacology, bringing together current research on regulation of drug targets, at a level appropriate for advanced undergrad and graduate students
    • Discusses the relevance of pharmacokinetics and drug development for the clinical application of drugs
    • Presents material from the perspective of drug targets and interaction, the theoretical basis of drug action analysis, and drug properties
    • Focuses on structure-function relationships of drug targets – informing about their biochemical and physiologic functions and experimental and clinical pathways for drug discovery and development
    • Has a companion website that offers a host of resources: short additional chapters about methodology, topics at the forefront of research, all figures and tables from the book, and Power Point slides

  • Pediatric Formulations
    La comanda in aproximativ 4 saptamani
    702.00 lei

    Until the 1990s, it was generally accepted that medicines were first developed for adults and their use in children was investigated later, if at all. One of the main tasks of hospital pharmacies was the manufacturing of child-appropriate formulations in a more or less makeshift way. The first change came in 1997 with U.S. legislation that rewarded manufacturers to do voluntary pediatric research. Ten years later, the European Union passed legislation that required manufacturers to discuss all pediatric aspects, including formulations, with the regulatory authorities as a condition of starting the registration procedure. In consequence, manufacturers must now cover all age groups, including the youngest ones. So far, pediatric formulations were more a focus for academic researchers. Through the changed regulatory environment, there is now a sudden high commercial demand for age-appropriate formulations. This book begins by highlighting the anatomical, physiological and developmental differences between adults and children of different ages. It goes on to review the existing technologies and attempts to draw a roadmap to better, innovative formulations, in particular for oral administration.

  • 767.00 lei

    Drug therapy via inhalation route is at the cutting edge of modern drug delivery research. There has been significant progress on the understanding of drug therapy via inhalation products. However, there are still problems associated with their formulation design, including the interaction between the active pharmaceutical ingredient(s) (APIs), excipients and devices. This book seeks to cover some of the most pertinent issues and challenges of such formulation design associated with industrial production and desirable clinical outcome. The chapter topics have been selected with a view to integrating the factors that require consideration in the selection and design of device and formulation components which impact upon patient usability and clinical effectiveness. The challenges involved with the delivery of macromolecules by inhalation to both adult and pediatric patients are also covered. Written by leading international experts from both academia and industry, the book will help readers (formulation design scientists, researchers and post-graduate and specialized undergraduate students) develop a deep understanding of key aspects of inhalation formulations as well as detail ongoing challenges and advances associated with their development.

  • 789.00 lei

    As the generic pharmaceutical industry continues to grow and thrive, so does the need to conduct adequate, efficient bioequivalence studies. In recent years, there have been significant changes to the statistical models for evaluating bioequivalence. In addition, advances in the analytical technology used to detect drug and metabolite levels have made bioequivalence testing more complex. The second edition of Handbook of Bioequivalence Testing has been completely updated to include the most current information available, including new findings in drug delivery and dosage form design and revised worldwide regulatory requirements. New topics include: A historical perspective on generic pharmaceuticals New guidelines governing submissions related to bioequivalency studies, along with therapeutic code classifications Models of noninferiority Biosimilarity of large molecule drugs Bioequivalence of complementary and alternate medicines Bioequivalence of biosimilar therapeutic proteins and monoclonal antibodies New FDA guidelines for bioanalytical method validation Outsourcing and monitoring of bioequivalence studies The cost of generic drugs is rising much faster than in the past, partly because of the increased costs required for approval―including those for bioequivalence testing. There is a dire need to re-examine the science behind this type of testing to reduce the burden of development costs―allowing companies to develop generic drugs faster and at a lower expense. The final chapter explores the future of bioequivalence testing and proposes radical changes in the process of biowaivers. It suggests how the cost of demonstrating bioequivalence can be reduced through intensive analytical investigation and proposes that regulatory agencies reduce the need for bioequivalence studies in humans. Backed by science and updated with the latest research, this book is destined to spark continued debate on the efficacy of the current bioequivalence testing paradigm.

  • 837.00 lei

    Description
    Ibuprofen has become one of the foremost pain-relieving medications world-wide with its proven safety and efficacy in a wide variety of painful and inflammatory conditions. It has also been widely investigated for application in a variety of painful and non-pain inflammatory states including cancer and neurodegenerative conditions, reflecting the unique and novel properties of the drug that would never have been foreseen from knowledge of the properties when it was initially discovered.
    • Edited by leading world expert with over 40 years record in research, teaching and as a scientific advisor in the field of anti-inflammatory/analgesic agents. Professor Kim Rainsford is also the founding Editor-in-Chief of the journal, Inflammopharmacology, as well as being an Associate Editor of The Journal of Pharmacy & Pharmacology.
    • Provides a thorough coverage of the medicinal chemistry and pharmaceutics of ibuprofen, and its pharmacokinetics in both humans and animals.
    • Includes molecular, pharmacological and toxicological studies, and discusses the safety and efficacy of non-prescription ibuprofen, including its side effects. Ibuprofen: Discovery, Development & Therapeutics provides a definitive reference on all the main aspects of the chemical and pharmaceutical properties, mechanisms of action and therapeutic uses of ibuprofen including its role in the prevention and treatment of rheumatic conditions, cancer and neurodegenerative conditions such as Alzheimer’s and Parkinson’s diseases.
    The book has its origins in a volume first published in 1999, since when there have been considerable advances in research and clinical studies on ibuprofen in the treatment of many inflammatory and even non-inflammatory states. This book will prove invaluable to scientists, clinicians, pharmacists and all those who need to know about the actions and uses of anti-inflammatory and analgesic drugs.

  • 892.00 lei

    Covering fundamentals and new developments in phytotherapy, this book combines pharmaceutical sciences and chemistry with clinical issues.
    • Helps readers better understand phytotherapy and learn the fundamentals of and how to analyze phytotherapeutic agents
    • Discusses phytotherapy in modern medicine, chemoprevention of disease, and alternatives to western medicines for specific diseases
    • Chapters summarizes the uses and applications of phytomedicines, by type like Chinese, Greco-Arab, Indian, European, and Ayurvedic
    • Includes international regulatory perspectives and discusses emerging regulations for various established and emerging markets

  • 1040.00 lei

    Functional foods and nutraceuticals have received considerable interest in the past decade largely due to increasing consumer awareness of the health benefits associated with food. Diet in human health is no longer a matter of simple nutrition: consumers are more proactive and increasingly interested in the health benefits of functional foods and their role in the prevention of illness and chronic conditions. This, combined with an aging population that focuses not only on longevity but also quality of life, has created a market for functional foods and nutraceuticals. A fully updated and revised second edition, Genomics, Proteomics and Metabolomics in Nutraceuticals and Functional Foods reflects the recent upsurge in "omics" technologies and features 48 chapters that cover topics including genomics, proteomics, metabolomics, epigenetics, peptidomics, nutrigenomics and human health, transcriptomics, nutriethics and nanotechnology. This cutting-edge volume, written by a panel of experts from around the globe reviews the latest developments in the field with an emphasis on the application of these novel technologies to functional foods and nutraceuticals.

  • Stockley's Drug Interactions
    La comanda in aproximativ 4 saptamani
    1230.00 lei

    Stockley's Drug Interactions : A source book of interactions, their mechanisms, clinical importance and management This eleventh edition of Stockley’s Drug Interactions is the most comprehensive and authoritative international source of drug interaction information. Stockley’s Drug Interactions, edited by Claire L Preston, remains the world’s most comprehensive and authoritative international reference book on drug interactions. Based upon thousands of published papers and reports this eleventh edition: · Covers interactions between therapeutic drugs, proprietary medicines, herbal medicines, foods, drinks, and drugs of abuse · Contains in-depth yet concise monographs in an easy-to-read format · Provides comprehensive details of the clinical evidence for the interactions under discussion, an assessment of their clinical importance, and clear guidance on managing the interaction in practice · Has a brief summary of the interaction in each monograph – perfect for the busy healthcare professional · Is fully referenced throughout · Contains almost 4500 monographs · Is global in coverage – inclusion of drugs used worldwide New in the 11th edition: · Over 350 new monographs added · Many existing monographs have been reviewed, revalidated, and updated · A comprehensive update and restructure of the chapter on Antidiabetic drugs, in-line with published literature · Addition of new advice regarding the concurrent use of aliskiren, ACE inhibitors, and angiotensin-II receptor antagonists · An updated list of drugs that have a risk of prolonging the QT interval · The addition of new drugs, including apixaban, apremilast, dolutegravir, lomitapide, mirabegron, the NS5A inhibitors (daclatasvir, ledipasvir, ombitasvir), the NS5B inhibitors (dasabuvir, sofosbuvir), the sodium-glucose co-transporter-2 inhibitors (canagliflozin, dapagliflozin, empagliflozin), and telavancin

  • Drug Facts and Comparisons 2016
    La comanda in aproximativ 4 saptamani
    1290.00 lei

    Drug Facts and Comparisons provides up-to-date information on over 22,000 Rx and 6,000 OTC products grouped by therapeutic category for ease of comparison. Drug Facts and Comparisons helps answer questions about actions, indications and contraindications, warnings and precautions, drug interactions, adverse reactions, administration and dosage, and pregnancy and lactation. Comparisons include drug to drug, dosage forms, and name brands to name brands and generics. Biologicals and antiparasitic drugs, IV solutions, and therapeutic ophthalmic preparations are also included. This hardbound edition includes the Drug Identifier 2016 CD-ROM, the premier tool for drug identification. Search more than 10,000 color images in seconds by drug name, imprint, NDC, color, shape, manufacturer, coating, scoring, clarity, and flavor. Features: ·Over 22,000 Rx and 6,000 OTC products, including generic and trade names ·More than 3,000 easy-to-read charts and comparative tables ·Drug Identifier 2016 CD-ROM offers more than 10,000 color images searchable by drug name, imprint, NDC, color, shape, manufacturer, coating, scoring, clarity, and flavor. ·Extensive manufacturer/distributor list

  • 2301.00 lei

    A comprehensive review of the current status of antidepressants - how we arrived at this point in their evolution and where we are going in both the near and the long term. It employs both a scientific and historical approach to accomplish these goals. This volume is intended for practitioners who use antidepressants on a daily basis in their practice as well as for the student and researcher. Each will find that it provides a comprehensive and logical approach to this important group of medications. This book is being published as we mark the end of the first 50 years of the modern antidepressant era.

  • 2330.00 lei

    Comprises almost 1,500 individual drug articles providing the coverage of adverse reactions and interactions. This title features encyclopedic format with drug monographs organised alphabetically. It provides systematic organization of information for easier reading including case histories to provide perspective on each listing.

  • 3225.00 lei

    The 9th Edition of the European Pharmacopoeia (EP), main volume and supplements, is legally binding and details the qualitative and quantitative composition of medicines, the tests to be carried out on medicines, the raw materials used in the production of medicines and on the intermediates of synthesis. The EP is a single reference work for the quality control of medicines in Europe. All producers of medicines or substances for pharmaceutical use must apply the quality standards of the European Pharmacopoeia for the marketing and use of these products in Europe. Earliest access to all European quality standards that come into effect on 1 January 2017. The European Pharmacopoeia is Europe’s legal and scientific benchmark for pharmacopoeial standards which contribute to delivering high quality medicines in Europe and beyond. It is applicable in 37 European countries and used in over 100 countries worldwide. It delivers crucial information earlier than any other pharmacopoeia – the 9th Edition will be released in mid-2016. With 121 new and 1,403 revised texts, over 50% of the 9th Edition’s content is new compared to the 8th Edition. The 9th Edition will consist of 3 initial volumes (9.0) and 8 non-cumulative supplements (9.1 to 9.8). Volumes 1, 2 and 3 combined contain 2329 monographs (including dosage forms), 358 general texts (including general monographs and methods of analysis) and around 2600 descriptions of reagents. New feature: it includes a direct link to the KNOWLEDGE database from each monograph. Mission The purpose of the European Pharmacopoeia is to promote public health by the provision of recognised common standards for the quality of medicines and their components. Such standards are to be appropriate as a basis for the safe use of medicines by patients. In addition, their existence facilitates the free movement of medicinal products in Europe and beyond. European Pharmacopoeia monographs and other texts are designed to be appropriate to the needs of: · regulatory authorities; · those engaged in the quality control of medicinal products and their constituents; · manufacturers of medicinal products and their individual components. The European Pharmacopoeia is widely used internationally. As globalisation and expansion in international trade present a growing need to develop global quality standards for medicines, the Commission works closely with all users of the Pharmacopoeia worldwide.

  • 5750.00 lei

    The USP 39-NF 34 standards will be deemed official by 1 May 2016. The USP is enforceable by the U.S. Food and Drug Administration for medicines manufactured and marketed in the United States. The USP-NF is a combination of two official compendia, the United States Pharmacopeia (USP) and the National Formulary (NF). The USP-NF contains standards for medicines, dosage forms, drug substances, excipients, biologics, compounded preparations, medical devices, dietary supplements, and other therapeutics. Includes a four-volume print main edition and two separate print supplements. Printed on thick, durable paper stock, for laboratory and manufacturing use. Each volume contains a complete table of contents and index. Shipped with a slipcase for easy access and storage. Highlights & Features More than 4,900 monographs with specifications for identity, strength, quality, purity, packaging, and labeling for substances and dosage forms. More than 300 general chapters providing clear, step-by-step guidance for assays, tests, and procedures Focus-specific charts and a combined index help you find the information you need Helpful sections on reagents, indicators, and solutions, plus reference tables Includes new General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings Key Features · 24 new and revised general chapters · 87 new and revised monographs · Focus-specific charts and a combined index help you find the information you need · Helpful sections on reagents, indicators, and solutions, plus reference tables The USP-NF offers convenient, comprehensive information for all phases of producing quality prescription, non-prescription, and compounded medicines; excipients; biologics; medical devices; and dietary supplements. It is essential for quality control, quality assurance, regulatory/compendial affairs, research and development, method development/analytical services, and corporate management. Benefits & Applications The USP–NF offers convenient, comprehensive information for all phases of producing quality prescription, nonprescription, and compounded medicines; excipients; biologics; medical devices; and dietary supplements. It is essential for quality control, quality assurance, regulatory/compendial affairs, research and development, method development/analytical services, and corporate management. USP–NF monographs and methods can help to Ensure compliance with required U.S. quality standards Work to world-recognized standards of precision and accuracy Validate test results against proven benchmarks Establish and validate in-house standard operating procedures, and specifications Expedite new product development and approvals A Valuable Reference for: Scientists, professionals, and students working in or with: Pharmaceuticals—prescription and nonprescription drugs Biological and biotechnology products Blood and blood products Compounded preparations Cosmetics Dietary supplements Excipients/other drug ingredients Medical devices Medical gases Medical libraries Pharmacies Schools of medicine and pharmacy Veterinary drugs

Scroll